COVID-19 Vaccines: How Efficient and Equitable Was the Initial Vaccination Process?

Area of Science:

• Global Health
• Epidemiology
• Vaccinology

Background:

• Over 11 billion COVID-19 vaccine doses administered globally.
• Persistent disparities in vaccination rates observed worldwide.
• Initiatives like COVAX and AVAT established to promote equitable vaccine access.

Purpose of the Study:

• Evaluate initial COVID-19 vaccination efforts.
• Assess the impact of distribution initiatives on equitable coverage.
• Analyze vaccine procurement and delivery trends.

Main Methods:

• Descriptive and trend analysis of COVID-19 vaccination data (Dec 2020 - Feb 2022).
• Data sourced from UNICEF, WHO, COVID-19 Task Force, and Our World in Data.
• Sub-group analysis by country income levels and context parameters.

Main Results:

• High-income countries (HICs) achieved 78.4% vaccination rate; LMICs 55.5%; LICs 10.9%.
• Significant vaccination rate differentials (>80% to <10%) within LMICs and LICs.
• COVAX supplied 53.3% of doses in LICs; bilateral agreements dominated LMICs (56.4%).

Conclusions:

• Despite global efforts, substantial COVID-19 vaccination inequities exist between income groups.
• COVAX played a crucial role in supplying LICs, while LMICs relied more on direct procurement.
• Future strategies must prioritize addressing vaccine inequities and enhancing global distribution mechanisms.